Ibnsina Pharma (EGX:ISPH)
Egypt
· Delayed Price · Currency is EGP 8.87
0.00 (0.00%)
At close: Mar 27, 2025
Ibnsina Pharma Ratios and Metrics
Market cap in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 26, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 9,022 | 7,056 | 3,517 | 2,419 | 3,907 | 4,886 | Upgrade
|
| Market Cap Growth | 100.64% | 100.64% | 45.37% | -38.08% | -20.04% | -39.01% | Upgrade
|
| Enterprise Value | 28,381 | 23,168 | 15,494 | 11,020 | 10,960 | 10,282 | Upgrade
|
| Last Close Price | 8.95 | 7.00 | 3.14 | 2.16 | 3.28 | 4.10 | Upgrade
|
| PE Ratio | 18.12 | 14.17 | 20.31 | 17.84 | 13.65 | 26.54 | Upgrade
|
| Forward PE | 10.60 | 11.62 | 10.44 | 3.90 | 9.83 | 12.70 | Upgrade
|
| PS Ratio | 0.16 | 0.13 | 0.10 | 0.11 | 0.18 | 0.26 | Upgrade
|
| PB Ratio | 4.44 | 3.47 | 2.43 | 1.92 | 2.69 | 3.58 | Upgrade
|
| P/TBV Ratio | 3.89 | 3.89 | 2.86 | 1.97 | 2.72 | 3.60 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 224.70 | Upgrade
| |
| P/OCF Ratio | - | 27.95 | 6.69 | - | 19.40 | Upgrade
| |
| PEG Ratio | 0.35 | 0.35 | 0.35 | 0.35 | 0.41 | 0.44 | Upgrade
|
| EV/Sales Ratio | 0.51 | 0.42 | 0.46 | 0.50 | 0.50 | 0.55 | Upgrade
|
| EV/EBITDA Ratio | 11.35 | 9.69 | 12.24 | 18.48 | 13.97 | 17.09 | Upgrade
|
| EV/EBIT Ratio | 12.57 | 10.26 | 13.46 | 22.85 | 16.42 | 21.04 | Upgrade
|
| EV/FCF Ratio | -23.96 | - | - | - | - | 472.83 | Upgrade
|
| Debt / Equity Ratio | 9.94 | 9.94 | 9.06 | 7.82 | 5.49 | 4.94 | Upgrade
|
| Debt / EBITDA Ratio | 8.08 | 8.08 | 9.83 | 14.82 | 9.47 | 10.92 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 310.22 | Upgrade
|
| Asset Turnover | 2.37 | 2.37 | 2.16 | 1.84 | 2.12 | 2.15 | Upgrade
|
| Inventory Turnover | 10.53 | 10.53 | 10.82 | 8.30 | 9.02 | 9.08 | Upgrade
|
| Quick Ratio | 0.67 | 0.67 | 0.68 | 0.60 | 0.66 | 0.48 | Upgrade
|
| Current Ratio | 1.00 | 1.00 | 1.00 | 1.00 | 1.03 | 1.06 | Upgrade
|
| Return on Equity (ROE) | 35.32% | 35.32% | 15.75% | 12.60% | 22.31% | 17.36% | Upgrade
|
| Return on Assets (ROA) | 5.98% | 5.98% | 4.58% | 2.50% | 4.06% | 3.51% | Upgrade
|
| Return on Capital (ROIC) | 7.67% | 7.67% | 5.60% | 2.93% | 4.75% | 4.13% | Upgrade
|
| Return on Capital Employed (ROCE) | 70.20% | 70.20% | 43.90% | 20.10% | 35.40% | 27.20% | Upgrade
|
| Earnings Yield | 5.52% | 8.71% | 6.08% | 7.13% | 8.05% | 4.60% | Upgrade
|
| FCF Yield | -13.13% | -16.79% | -6.49% | -18.05% | -12.49% | 0.45% | Upgrade
|
| Dividend Yield | 0.00% | - | - | - | 2.62% | - | Upgrade
|
| Payout Ratio | 4.17% | 4.17% | 10.74% | 81.35% | 4.63% | 36.51% | Upgrade
|
| Buyback Yield / Dilution | - | - | 22.58% | -16.25% | - | Upgrade
| |
| Total Shareholder Return | - | - | 22.58% | -13.63% | - | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.